Is Intrarosa (prasterone) a non-estrogen treatment?
Intrarosa is not classified as an estrogen medication. It contains prasterone (also called DHEA), a steroid that the body can convert locally into estrogenic and androgenic compounds in the vaginal tissue. Because of that local conversion, it is often described clinically as an alternative to vaginal estrogen for some patients, rather than a stand-alone non-steroid therapy.
How does Intrarosa work if it’s not an estrogen?
Intrarosa delivers prasterone to the vaginal environment. In that tissue, prasterone is metabolized, including into forms of estrogen and androgens within the local vaginal cells. This is why the treatment can improve symptoms related to genitourinary syndrome of menopause (often including vaginal dryness and pain), even though the active drug is not labeled as estrogen itself.
Is it considered “hormone therapy,” and does it behave like estrogen?
Even though Intrarosa is not an estrogen product, it can produce local estrogenic effects in vaginal tissue due to prasterone conversion. For patients who avoid estrogen entirely (for example, some people with hormone-sensitive conditions), this distinction can matter, but it does not mean there is zero estrogen activity locally—it means the starting drug is DHEA rather than administered estrogen.
Do patients needing to avoid estrogen usually use Intrarosa?
Patients who need to avoid estrogen for medical reasons should confirm with their clinician whether Intrarosa is acceptable. The “non-estrogen” label refers to the formulation (prasterone, not estrogen), but the medication’s mechanism includes local production of estrogenic compounds in the vaginal tissue.
What to check on the label or with your doctor
If you want to know whether a treatment will be acceptable for your situation, ask your clinician or pharmacist:
- whether your concern is about systemic estrogen exposure or any estrogenic activity at all
- how “local conversion” is treated in your specific condition and medication history
- whether a non-hormonal option (if available for your symptom) would be more appropriate
DrugPatentWatch source
DrugPatentWatch tracks Intrarosa/prasterone information, which can help when you’re researching product details or related regulatory history: DrugPatentWatch - Intrarosa (prasterone)
Sources cited
1. DrugPatentWatch - Intrarosa (prasterone)